Vaccinating young males and females against several types of human papillomavirus (HPV) could dramatically reduce the incidence of HPV-related cancers worldwide, according to Douglas Lowy, M.D., deputy director of the National Cancer Institute.

Two urologic surgeons at Vanderbilt-Ingram Cancer Center are among a leading group of cancer physicians using an innovative new imaging agent and blue light system to “light up” cancerous cells inside the bladder.

Vanderbilt researchers report that they have found a factor involved in the persistence of embryonic cells implicated in childhood liver cancer.

The protein TIP-1 appears to be a novel prognostic marker for glioblastoma and may be a good therapeutic target for disrupting tumor-driven blood vessel development.

Combining another drug with platinum-based chemotherapies may be more effective against ovarian cancer.

Nine Vanderbilt University faculty members named to endowed chairs were honored for outstanding academic achievements Dec. 12 during a celebration at the Student Life Center.